melanotan intranasal brain nanotherapeutics for targeting and clinical studies in Parkinson's disease My first media interview about
My first media interview about the dangers of Melanotan II (tanning peptide) was 13 years ago. I discuss this again with @abcnews_au here. Thank you Dr @timpiatkowski for sharing your research insights You Should Avoid Using Nasal Tanning Sprays Intranasal drug delivery: The interaction between nanoparticles and the nose to brain pathway ScienceDirect Emerging Threat: Melanotan, Repackaging, and Online Sales
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

